Considerations in selecting the appropriate implantable device in post-myocardial infarction syncopal patients with mild systolic dysfunction.

08:00 EDT 9th July 2019 | BioPortfolio

Summary of "Considerations in selecting the appropriate implantable device in post-myocardial infarction syncopal patients with mild systolic dysfunction."

No Summary Available


Journal Details

This article was published in the following journal.

Name: Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese
ISSN: 2241-5955


DeepDyve research library

PubMed Articles [9719 Associated PubMed Articles listed on BioPortfolio]

Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study.

Sudden cardiac death (SCD) annual incidence is 0.6-1% in post-myocardial infarction (MI) patients with left ventricular ejection fraction (LVEF)≥40%. No recommendations for implantable cardioverter-...

The relevance of microRNA in post-infarction left ventricular remodelling and heart failure.

Myocardial infarction and post-infarction left ventricular remodelling involve a high risk of morbidity and mortality. For this reason, ongoing research is being conducted in order to learn the mechan...

A Chymase Inhibitory RNA Aptamer Improves Cardiac Function and Survival after Myocardial Infarction.

We have reported that mast cell chymase, an angiotensin II-generating enzyme, is important in cardiovascular tissues. Recently, we developed a new chymase-specific inhibitory RNA aptamer, HA28, and we...

The impact of age on cardiac function and extracellular matrix component expression in adverse post-infarction remodeling in mice.

The aim of this study was to describe the potential associations of the expression of matricellular components in adverse post-infarction remodeling of the geriatric heart. In male geriatric (OM, age:...

Adrenomedullin Induces Cardiac Lymphangiogenesis After Myocardial Infarction and Regulates Cardiac Edema Via Cx43.

Cardiac lymphangiogenesis contributes to the reparative process post myocardial infarction (MI), but the factors and mechanisms regulating it are not well understood.

Clinical Trials [9940 Associated Clinical Trials listed on BioPortfolio]

IRIS : Use of Implantable Defibrillator in High-Risk Patients Early After Acute Myocardial Infarction

Of the patients who survive hospitalization after an acute myocardial infarction, ca. 10% die of sudden cardiac death in the following 2 years. The prognosis appears not improved by medica...

Continuous Rhythm Monitoring in Patients After Acute Myocardial infaRction andpREServed Lef venTricle Ejection Fraction (ARREST)

The trial will inform whether detection of ventricular arrhythmias by means of implantable loop recorder (ILR) can help to predict SCD in the large population of survivors of a myocardial ...

The Prevention of Myocardial Enlargement and Dilatation Post Myocardial Infarction Study

This study is designed to evaluate the effect of pacing on post-MI patients.

MCG Post Myocardial Infarction Study

The study is being performed to evaluate a new portable medical device, the Creavo Vitalscan Magnetocardiograph (Vitalscan) on patients who have had a confirmed myocardial infarction (hear...

Assessment of Spontaneous Baroreflex Sensitivity in Carriers of Implantable Cardioverter Defibrillators: Association With Disorders of the Ventricular Heart Rate. Case-control Study

We must implement 8 implantable cardioverter defibrillators (ICDs) to save a life in 3 years after myocardial infarction (MI) in primary prevention. Only the ejection fraction of the left...

Medical and Biotech [MESH] Definitions

Laceration or tearing of cardiac tissues appearing after MYOCARDIAL INFARCTION.

MYOCARDIAL INFARCTION in which the anterior wall of the heart is involved. Anterior wall myocardial infarction is often caused by occlusion of the left anterior descending coronary artery. It can be categorized as anteroseptal or anterolateral wall myocardial infarction.

A myocardial infarction that does not produce elevations in the ST segments of the ELECTROCARDIOGRAM. ST segment elevation of the ECG is often used in determining the treatment protocol (see also ST Elevation Myocardial Infarction).

A clinical syndrome defined by MYOCARDIAL ISCHEMIA symptoms; persistent elevation in the ST segments of the ELECTROCARDIOGRAM; and release of BIOMARKERS of myocardial NECROSIS (e.g., elevated TROPONIN levels). ST segment elevation in the ECG is often used in determining the treatment protocol (see also NON-ST ELEVATION MYOCARDIAL INFARCTION).

Disease-related laceration or tearing of tissues of the heart, including the free-wall MYOCARDIUM; HEART SEPTUM; PAPILLARY MUSCLES; CHORDAE TENDINEAE; and any of the HEART VALVES. Pathological rupture usually results from myocardial infarction (HEART RUPTURE, POST-INFARCTION).

Quick Search

DeepDyve research library

Searches Linking to this Article